HR 661 · in committee · niche
MIRACLE Medical Technology Act of 2025
- healthcare
What this bill does
- The bill requires HHS to establish a U.S.-Israel collaboration program for developing and delivering healthcare products and services.
- Researchers, healthcare companies, and patients in both countries are affected by the expanded medical technology development.
- HHS may create a joint Health Care Collaboration Center; no specific appropriations or timeline are detailed in the summary.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would a U.S.-Israel medical technology collaboration program affect drug development timelines and costs for American patients compared to current processes?
- 02
What specific healthcare products or services should be prioritized in the collaboration, and how would HHS decide without detailed criteria in the legislation?
- 03
What oversight mechanisms should ensure that jointly developed medical technologies remain affordable and accessible to both American and Israeli patients?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-FL-16
Vern Buchanan
Citizen cosponsors
0
In Congress
3/ 435
House Reps cosponsoring
Introduced 2025-01-23
Joining the bill
Legislative timeline
2025-01-23 · house · IntroReferral
Referred to the House Committee on Energy and Commerce.
2025-01-23 · IntroReferral
Introduced in House
2025-01-23 · IntroReferral
Introduced in House

Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.